In addition, the upregulation of glucagon-like peptides and proglucagon expression, such as Fiaf in the intestine and adiponectin expression in the B-epiticular fat pad, has been shown to be effective in preventing obesity and insulin resistance [16]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.